Results 111 to 120 of about 1,574 (183)

Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study. [PDF]

open access: yesBreast
Pontolillo L   +28 more
europepmc   +1 more source

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications. [PDF]

open access: yesNPJ Breast Cancer
Griguolo G   +18 more
europepmc   +1 more source

Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation. [PDF]

open access: yesReprod Biol Endocrinol
Mathieu d'Argent E   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy